HB-1 for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Mar 2026: Trial registered, NCT07499440
  2. 3 Jun 2026: Trial started, NCT07499440

The trials

NCT07499440: Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder

State
Under way
Phase
Phase 2
People
200 planned
Started
3 Jun 2026
Primary completion
Sep 2027
Arms
HB-1
Results
None posted
  1. 30 Mar 2026: Trial registered
  2. 3 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.